Finished
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
NCT06020287 · Nanjing University School of Medicine · Updated 31 Aug 2023
- What is being tested
- the robot-assisted laparoscopic radical prostatectomy
- For
- Prostatectomy; Prostate Neoplasm
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 233 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Sept 2020, ends 27 Dec 2022. Registered 31 Aug 2023.
- Results
- None posted yet.
In the researchers' words
The goal of this observational study was to compare the perioperative outcomes, postoperative urinary control rates and positive surgical margin (PSM) rates of the robot-assisted laparoscopic radical prostatectomy combined anterior and posterior approach (AP-RARP) with the Retzius-sparing approach (RS-RARP) and anterior approach (anterior-RARP) in the treatment of prostate cancer. The main question it aims to answer was: • The early therapeutic efficacy of the robot-assisted laparoscopic radical prostatectomy combined anterior and posterior approach Participants has been underwent: * AP-RARP * RS-RARP * anterior-RARP Researchers compared the three groups to see if AP-RARP combines the advantages of anterior and posterior RARP and is a feasible surgical option for the treatment of prostate cancer.
Sites
- Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolNanjing, Jiangsu, China